Survival after redo-lung transplantion for CLAD according to phenotype - A multi-center study

S. Verleden, J. Todd, M. Sato, S. Palmer, T. Martinu, E. Pavlisko, B. Vanaudenaerde, R. Vos, G. Verleden, T. Saito, H. Oish, G. Warnecke, M. Greer, J. Gottlieb, A. Haverich (Leuven, Belgium; Durham, United States Of America; Toronto, Canada; Hannover, Germany)

Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Session: Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Session type: Oral Presentation
Number: 1428

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Verleden, J. Todd, M. Sato, S. Palmer, T. Martinu, E. Pavlisko, B. Vanaudenaerde, R. Vos, G. Verleden, T. Saito, H. Oish, G. Warnecke, M. Greer, J. Gottlieb, A. Haverich (Leuven, Belgium; Durham, United States Of America; Toronto, Canada; Hannover, Germany). Survival after redo-lung transplantion for CLAD according to phenotype - A multi-center study. Eur Respir J 2014; 44: Suppl. 58, 1428

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Osteoporosis in lung transplant patients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


Lung transplantation for silicosis, report of 17 patients
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

Cohort characteristics and chronic lung allograft dysfunction (CLAD) adjudication in a FP-7 funded project, Systems prediction of CLAD (SysCLAD)
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015

Lung complications after liver transplantation in children: The Swiss experience
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013


Clinical impact of the complications related to lung transplantation
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


Orthotopic lung transplantation in a single-mismatch-based mouse model shows signs of chronic lung allograft dyfunction (CLAD)
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

A new lung donor scoring system
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Extracorporeal photopheresis in lung transplant:The initial experience in our hospital
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014


Hypogammaglobulinemia in lung transplant candidates
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016

Pirfenidone in Chronic Lung Allograft Dysfunction after Lung Transplantation: A single-centre experience.
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017



Retrospective analysis of patients with interstitial lung disease on lung-transplantation waiting-list
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

Predictive factors of restrictive allograft syndrome after lung-transplantation
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation.
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Timeline of pulmonary complications after hematopoietic stem cell transplantation in children
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016

Long-term outcome of lung recipients: The role of CD4+CD25highCD127- treg
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Lung transplantation and coronary artery disease - a relative contraindication?
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

Septic shock – A contraindication for bridge to transplant?
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


Evaluation of pulmonary functions after hematopoietic stem cell transplantation in children
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015